CTLA4 and breast carcinoma: For example, monoclonal antibodies or bispecific antibodies corresponding to antigens such as EGFR, VEGFR, PD-L1, TGFB1, and CTLA-4 have been used to treat tumors, such as acute lymphoma leukemia, colorectal cancer, and breast cancer (62–68).